Topic | Pharmaceuticals | The Sydney Morning Herald

We’re sorry, this feature is currently unavailable. We’re working to restore it. Please try again later.

Pharmaceuticals

Advertisement
‘Orphaned inventions’: Life-saving AI discoveries trapped in legal black hole

‘Orphaned inventions’: Life-saving AI discoveries trapped in legal black hole

The law insists inventors have to be human. But that means we’re missing out on groundbreaking medicine and technology developed by AI.

  • by Angus Dalton

Latest

Medicine to prevent bone loss may help lower risk of ovarian cancer

Medicine to prevent bone loss may help lower risk of ovarian cancer

A study of tens of thousands of women suggests a common bone density drug could lower the risk of ovarian cancer.

  • by Stuart Layt
Aussie tech in postnatal depression pill breakthrough
Exclusive
Biotech

Aussie tech in postnatal depression pill breakthrough

Researchers at Monash University are hoping a technology they have invented will enable women who have to undergo lengthy intravenous infusion treatments for postnatal depression to take a simple pill instead.

  • by Emma Koehn
Is Dolly Parton-backed biotech Moderna a good investment?
The long and short of it
Stock picking

Is Dolly Parton-backed biotech Moderna a good investment?

It’s the global vaccine maker that has delivered huge returns for early backers, but can Moderna continue its growth in a post-COVID world?

  • by Emma Koehn
Medicinal cannabis product CBD does not affect driving ability, research finds

Medicinal cannabis product CBD does not affect driving ability, research finds

New research confirms medicinal cannabis product CBD does not impair people’s ability to drive even at high doses.

  • by Stuart Layt
Celebrating the cultural differences
Opinion
Column 8

Celebrating the cultural differences

A new type of nuisance call.

Advertisement
‘It’s scary, the thought of not having access’: New anti-depressant considered for PBS

‘It’s scary, the thought of not having access’: New anti-depressant considered for PBS

Esketamine nasal spray was approved by Australia’s medical regulator last year, but without a PBS listing it will cost patients more than $3000 for an eight-week course.

  • by Mary Ward
People dying of COVID while life-saving drugs go unused, doctors say

People dying of COVID while life-saving drugs go unused, doctors say

Top doctors have warned that vulnerable patients who test positive to COVID-19 are missing out on potentially life-saving antiviral treatments.

  • by Lucy Carroll
AI to help diagnose whether COVID patient will suffer severe effects

AI to help diagnose whether COVID patient will suffer severe effects

Researchers will use machine learning to develop a tool to predict whether someone will develop severe COVID-19 symptoms, to help manage the disease into the future.

  • by Stuart Layt
Probiotic treatment for asthma hailed as breath of fresh air

Probiotic treatment for asthma hailed as breath of fresh air

Biome Australia’s treatment is not a cure for asthma, but a comprehensive new study shows it can reduce the number of attacks.

  • by Stuart Layt
Popular weight loss tablets banned by regulator over lack of evidence

Popular weight loss tablets banned by regulator over lack of evidence

FatBlaster Max weight loss tablets have already been removed from some websites after a decision by the Therapeutic Goods Administration.

  • by Mary Ward